The Libyan Audit Bureau in Tripoli has given the green light for buying a newly developed vaccine for Coronavirus in a contract that is worth over 9.6 million dollars.
The Libyan Audit Bureau said in a statement on Saturday that the agreement to allow the purchase of the vaccine came after a demand by the Health Ministry of the Government of National Accord which is part of an international convention for coronavirus vaccine purchase.
The Audit Bureau called on the Health Ministry to take the necessary measures for storing the vaccine as per the international standards so it can be accessed by all Libyans across the country.
Meanwhile, a Covid-19 vaccine being developed by Pfizer and Germany’s BioNTech has been found to be more than 90 per cent effective, in a breakthrough that could make the shot available for use by the end of the year if drug authorities give it the green light.
On Sunday, the Libyan National Center for Disease Control said it had registered 22 deaths, 974 positive cases and 874 recoveries of Covid-19, bringing the total of cases to over 73.600, 28.452 of which are active, 44.113 recovered and 1017 deaths.
